Bayer Announces Signing of Strategic Framework Agreement with JD Pharmacy

Beijing, May 23, 2018 - Fortune 500 company Bayer announces today the signing of a strategic framework agreement with JD Pharmacy, joining its “JD Health Care Plan”. In line with the principles of, “Making Use of Competitive Advantages, Mutual Advancement, Long-Term Cooperation and Mutual Benefit,” both parties will promote the strategic partnership and strive to expand the depth and breadth of their cooperation. This will help consumers better understand self-care and provide more self-care solutions.


Ms. Celina Chew, President of Bayer Greater China Group, took part in the ceremony commemorating the second anniversary of JD Pharmacy and signing of the strategic framework agreement. She also served as the company’s representative to receive the “JD Pharmacy 2-year Anniversary TOP Brand Award.”


“In China, the government’s `Healthy China 2030’ plan aims to provide equal access to health services for every citizen by 2030. Self-care will be one of the key drivers in the overall medical system to achieve this goal. Due to the strength of its renowned and trusted brands, Bayer Consumer Health has a vast customer base in China. As the public becomes more health aware, the concept of self-care is becoming ever more popular. ” Ms. Chew said, “This strategic partnership between Bayer and JD Pharmacy will go further than most commercial partnerships. It covers a number of ventures, including flagship store development, precision marketing, TCM turnaround plan, patient education, intellectual cloud pharmacist service platform, CSR projects and etc. We are extremely grateful for the opportunity to establish this strategic partnership with JD Pharmacy, and we believe this strategic partnership will promote the development of both our companies.”


Through this strategic partnership with JD Pharmacy, Bayer Consumer Health will set up flagship store at JD platform, further develop its sales and service channels with JD’s resources, allowing consumers to purchase Bayer products even more quickly and conveniently. Bayer has abundant health care expertise resources and competitive advantages in the field of self-care; while JD platform has one of the fastest, most advanced logistical networks in e-commerce, abundant online sales resources and big data advantages.


The strategic partnership will maximize both parties’ advantages in health care resources, big data, online channels, logistics and distribution, fundamentally enhancing the competency of both parties, achieving a win-win solution. It will also better meet the consumer’s ever-increasing need for self-care management, providing more and better self-care solutions.


About Bayer

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35.0 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion. For more information, go to